• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Orgenesis Inc. - Common Stock (NQ:ORGS)

2.110 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orgenesis Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio
March 26, 2026
Plano, Texas--(Newsfile Corp. - March 26, 2026) - Okogen Inc., a biotechnology company developing... 
Via Newsfile
Topics Intellectual Property
News headline image
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
March 06, 2025
Via ACCESS Newswire
News headline image
Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings
January 28, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 18, 2024
 
Via Benzinga
News headline image
Dow Falls Over 100 Points; Netflix Posts Upbeat Results ↗
October 18, 2024
 
Via Benzinga
Topics Stocks
News headline image
Why Orgenesis (ORGS) Stock Is Down 23% Today ↗
September 23, 2024
Orgenesis shares are trading lower by 23% during Monday's session. The company announced a 1-for-10 reverse stock split. 
Via Benzinga
News headline image
ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024 ↗
August 09, 2024
Orgenesis just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023 ↗
May 31, 2024
Orgenesis just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
October 18, 2024
 
Via Benzinga
News headline image
Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗
October 18, 2024
 
Via Benzinga
News headline image
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket ↗
September 24, 2024
 
Via Benzinga
News headline image
Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗
August 13, 2024
 
Via Benzinga
News headline image
ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024 ↗
May 21, 2024
ORGS stock results show that Orgenesis missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
June 21, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
May 21, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
April 10, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
April 10, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
April 04, 2024
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
April 04, 2024
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
April 03, 2024
 
Via Benzinga
News headline image
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
April 02, 2024
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
April 02, 2024
 
Via Benzinga
News headline image
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
April 01, 2024
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
February 19, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
February 19, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
February 15, 2024
 
Via Benzinga
News headline image
Dakota Gold And 2 Other Stocks Under $3 Insiders Are Buying ↗
February 15, 2024
The Dow Jones index closed higher by more than 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
Topics Stocks
News headline image
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
February 15, 2024
Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings. 
Via Benzinga
News headline image
EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic ↗
January 31, 2024
Orgenesis to acquire full ownership of Octomera & Metalmark to receive royalty & proceeds in exchange. Shift to decentralized production supported by regulators. 
Via Benzinga
News headline image
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
January 19, 2024
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap